---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-033856"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2026-05-12T11:01:41+00:00"
generated_at: "2026-05-12T11:08:45.874030+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Opus Genetics Q1 net loss $65.5M; cash $60M; enters $35M Oberland debt facility

## Summary
- Net loss $65.5M ($0.75 per share) vs $8.2M loss a year ago; includes non-cash warrant liability fair value change.
- Revenue $2.2M from Viatris collaboration, down from $4.4M.
- Cash $60M at March 31; post-quarter $35M senior secured notes from Oberland Capital plus $5M equity; total ~$90M funds into 2029.
- LCA5 program accepted into FDA's RDEP program; pivotal Phase 3 enrollment ongoing, dosing expected Q4 2026.
- BEST1 Cohort 1 topline data expected September 2026; R&D Science Forum June 16.

## SEC filing metadata
- accession: 0001628280-26-033856
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2026-05-12T11:01:41+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000162828026033856/0001628280-26-033856-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000162828026033856/ird-20260512.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-033856
- JSON: https://secwatch.observer/filing/0001628280-26-033856.json
- Plain text: https://secwatch.observer/filing/0001628280-26-033856.txt

## Key facts
- Earnings Releases
  Opus Genetics, Inc. reported financial results for the first quarter ended March 31, 2026.
  - Period: the first quarter ended March 31, 2026
  - Result: reported results
  source text: On May 12, 2026 , Opus Genetics, Inc., a Delaware corporation (the “Company”), issued a press release announcing its financial results for the first quarter ended March 31, 2026 .
  evidence_url: https://www.sec.gov/Archives/edgar/data/1228627/000162828026033856/0001628280-26-033856-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.